Announcements Trials

Browse Landscape

Phase

Status

Terminated 1 Recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pancreatic Neoplasms 5 Pancreatic Ductal Adenocarcinoma (PDAC) 1 Neoplasm Metastasis 1 Gastro-enteropancreatic neuroendocrine tumor 1 Carcinoma, Pancreatic Ductal 1 Carcinoma, Islet Cell 1 Biliary Tract Neoplasms 1

Interventions

Gemcitabine 11 Cisplatin 8 pembrolizumab 2 Oxaliplatin 2 Nivolumab 2 Docetaxel 2 Capecitabine 2 trametinib 1 titanium silicide 1 telotristat ethyl 1 sovateltide 1 niraparib 1 milademetan 1 folfirinox 1 dostarlimab 1 devimistat 1 cytokine inducible SH2-containing protein 1 brigimadlin 1 bintrafusp alfa protein, human 1 becatecarin 1 adagrasib 1 Sorafenib 1 S 1 (combination) 1 Pancreaticojejunostomy 1 NUC-1031 1 Leucovorin 1 Hydroxychloroquine 1 Fluorouracil 1 Cetuximab 1 Catheter Ablation 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Biliary Tract Neoplasms × folfirinox × Clear all

NCT03291899 2024-01-17

FBI-TRAC

King Faisal Specialist Hospital & Research Center

Phase 2 Terminated

Gastrointestinal

Biliary Tract Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡